XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total GD Culture Group Limited Shareholders’ Equity
Non- Controlling Interest
Stock Subscription Receivable
Accumulated Deficit Statutory Reserves
Accumulated Deficit Unrestricted
Total
Balance at Dec. 31, 2022 $ 184 $ 60,124,087   $ 179,460 $ 3,467,124 $ 4,467 $ (56,841,074) $ 3,467,124
Balance (in Shares) at Dec. 31, 2022 1,844,877                  
Net loss   (21,309) (21,309) (21,309)
The cancellation of the common stock $ (13) (947,987)   (948,000) (948,000)
The cancellation of the common stock (in Shares) (133,333)                  
Foreign currency translation   10,188 10,188 10,188
Balance at Mar. 31, 2023 $ 171 59,176,100   189,648 2,508,003 4,467 (56,862,383) 2,508,003
Balance (in Shares) at Mar. 31, 2023 1,711,544                  
Balance at Dec. 31, 2022 $ 184 60,124,087   179,460 3,467,124 4,467 (56,841,074) 3,467,124
Balance (in Shares) at Dec. 31, 2022 1,844,877                  
Net loss                     (3,707,567)
Balance at Sep. 30, 2023 $ 305 68,544,206   71,468 6,903,676 5,383,648 (1,370,614) 4,467 (60,446,156) 12,187,324
Balance (in Shares) at Sep. 30, 2023 3,053,563                  
Balance at Mar. 31, 2023 $ 171 59,176,100   189,648 2,508,003 4,467 (56,862,383) 2,508,003
Balance (in Shares) at Mar. 31, 2023 1,711,544                  
Net loss   (155,498) (155,498) (155,498)
Issuance of common stock for Cash $ 115 8,618,125   8,718,240 8,718,240
Issuance of common stock for Cash (in Shares) 1,154,519                  
Issuance of common stock for acquisition $ 19 749,981   750,000 750,000
Issuance of common stock for acquisition (in Shares) 187,500                  
Foreign currency translation   (122,471) (122,471) (122,471)
Balance at Jun. 30, 2023 $ 305 68,544,206   67,177 11,698,274 4,467 (57,017,881) 11,598,274
Balance (in Shares) at Jun. 30, 2023 3,053,563                  
Net loss   (3,428,275) (102,485) (3,428,275) (3,530,760)
Contribution by noncontrolling interest shareholder   5,486,133 5,486,133
Stock subscription receivable from issuance of common stock   (1,370,614) (1,370,614) (1,370,614)
Foreign currency translation   4,291 4,291 4,291
Balance at Sep. 30, 2023 $ 305 68,544,206   71,468 6,903,676 5,383,648 $ (1,370,614) $ 4,467 $ (60,446,156) 12,187,324
Balance (in Shares) at Sep. 30, 2023 3,053,563                  
Balance at Dec. 31, 2023 $ 545 77,530,221 $ (69,358,225) 175,306 8,347,847 3,813,636       12,161,483
Balance (in Shares) at Dec. 31, 2023 5,453,416                  
Net loss (3,978,628) (3,978,628) (178,911)       (4,157,539)
Issuance of common stock for Cash $ 81 829,798 829,879       829,879
Issuance of common stock for Cash (in Shares) 810,277                  
Issuance of common stock for acquisition $ 40 3,150,753 3,150,793 (3,150,793)      
Issuance of common stock for acquisition (in Shares) 400,000                  
Exercise of pre-funded warrants $ 57 597 654       654
Exercise of pre-funded warrants (in Shares) 567,691                  
Exercise of Registered Warrants $ 71 (71)      
Exercise of Registered Warrants (in Shares) 709,877                  
Foreign currency translation 78,891 78,891 (94,000)       (15,109)
Fair value changes of convertible notes receivable 54,849 54,849       54,849
Balance at Mar. 31, 2024 $ 794 81,511,298 (73,336,853) 309,046 8,484,285 389,932       8,874,217
Balance (in Shares) at Mar. 31, 2024 7,941,261                  
Balance at Dec. 31, 2023 $ 545 77,530,221 (69,358,225) 175,306 8,347,847 3,813,636       12,161,483
Balance (in Shares) at Dec. 31, 2023 5,453,416                  
Net loss                     (11,589,784)
Exercise of pre-funded warrants                     654
Balance at Sep. 30, 2024 $ 1,017 82,759,075 (80,663,233) 218,812 2,315,671 285,442       2,601,113
Balance (in Shares) at Sep. 30, 2024 10,171,024                  
Balance at Mar. 31, 2024 $ 794 81,511,298 (73,336,853) 309,046 8,484,285 389,932       8,874,217
Balance (in Shares) at Mar. 31, 2024 7,941,261                  
Net loss (3,585,181) (3,585,181) (7,731)       (3,592,912)
Issuance of common stock for acquisition $ 156 1,247,844 1,248,000       1,248,000
Issuance of common stock for acquisition (in Shares) 1,560,000                  
Foreign currency translation (3,521) (3,521) (1,281)       (4,802)
Fair value changes of convertible notes receivable (93,912) (93,912)       (93,912)
Balance at Jun. 30, 2024 $ 950 82,759,142 (76,922,034) 211,613 6,049,671 380,920       6,430,591
Balance (in Shares) at Jun. 30, 2024 9,501,261                  
Net loss (3,741,199) (3,741,199) (98,134)       (3,839,333)
Exercise of pre-funded warrants $ 58 (58)      
Exercise of pre-funded warrants (in Shares)   577,007                  
Exercise of Registered Warrants $ 9 (9)      
Exercise of Registered Warrants (in Shares)   92,756                  
Foreign currency translation 7,305 7,305 2,656       9,961
Fair value changes of convertible notes receivable (106) (106)       (106)
Balance at Sep. 30, 2024 $ 1,017 $ 82,759,075 $ (80,663,233) $ 218,812 $ 2,315,671 $ 285,442       $ 2,601,113
Balance (in Shares) at Sep. 30, 2024 10,171,024